.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Farmers Insurance
Novartis
Teva
Julphar
Chubb
Cantor Fitzgerald
QuintilesIMS
McKesson

Generated: June 25, 2017

DrugPatentWatch Database Preview

SYPRINE Drug Profile

« Back to Dashboard

What is the patent landscape for Syprine, and what generic Syprine alternatives are available?

Syprine is a drug marketed by Aton and is included in one NDA.

The generic ingredient in SYPRINE is trientine hydrochloride. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trientine hydrochloride profile page.

Summary for Tradename: SYPRINE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list71
Clinical Trials: see list3
Patent Applications: see list97
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SYPRINE at DailyMed

Pharmacology for Tradename: SYPRINE

Drug ClassMetal Chelator
Mechanism of ActionMetal Chelating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aton
SYPRINE
trientine hydrochloride
CAPSULE;ORAL019194-001Nov 8, 1985RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Baxter
McKesson
Novartis
Boehringer Ingelheim
Cipla
Farmers Insurance
Teva
Harvard Business School
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot